Key facts
- Nanos Medical’s last known valuation is $1.3B (Jan 2025).
- It has raised $289.1M; the latest was Later Stage VC ($46.2M) in Jan 2025.
- Notable investors include F-Prime Capital, Qiming Venture Partners, Eight Roads, Yunfeng Capital, Marathon Venture Partners — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Nanos Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Nanos Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nanos Medical
Manufacturer and developer of disposable interventional medical devices intended to focus on the ENT field. The company offers sinus balloon catheter, eustachian tube balloon, disposable nasopharyngeal airway, nasolacrimal balloon, and sinus drug eluting stent, thereby enabling hospitals and patients to have advanced medical devices and treatments.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2015
- Website
- nanosmedical.com/
- Ownership
- Privately Held (backing)
Nanos Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nanos Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nanos Medical in its N-PORT filings yet. We sweep new filings monthly.